FOR THE ATTENTION OFCONTRACTORS PROVIDING LIVING WELL SERVICE
Dear Colleague
Please find for your attention, correspondence from Kathryn Turner, Pharmacy Lead, HSCB and Stephen Wilson, Assistant Director of Communications and Knowledge Management, PHA.
Summary
Living Well Campaign ‘Vaccinations’ launched in December 2020 – if you have not received your resource pack please email reception.pha@hscni.net
Phase 2 resources of the ‘Vaccinations’ campaign, relating specifically to the COVID vaccination program, are currently being distributed – if not received by 13th January 2021 please email reception.pha@hscni.net
Action
As per the service specification, you must display the posters in at least one window unit of the pharmacy.
Reminder
As per previous correspondence your pharmacy is required to complete a short online evaluation survey for the previous LW campaign ‘Looking after your health and wellbeing during COVID-19’.
If you are yet to submit your pharmacy’s survey response, please complete here by Monday 18th January 2021.
Yours sincerely
SENT ON BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague
Please find correspondence from the BSO here which outlines the timetable for prescription submissions to the BSO until April 2021.
Please note: To support contractors who have opted to bring their second December prescription submission directly to BSO, the BSO reception will remain open until 9pm on Tuesday 12th January 2021. It is important that any prescriptions being brought directly to BSO are handed to BSO personnel in the BSO reception and signed in accordingly.
Yours sincerely
SENT ON BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague
The Department of Health has written to contractors detailing amendments that have been made to the Human Medicines Regulations 2012 (see here).
The Statutory Instrument (SI) titled The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020 was laid before Parliament on the 18th December 2020 and a can be accessed at:www.legislation.gov.uk/id/uksi/2020/1594
Among other amendments, the SI provides that Patient Group Directions (PGDs) allowing a retail pharmacy business to administer COVID-19 or influenza vaccines may be used at a location other than a registered pharmacy, thus making it lawful for administration of such vaccines away from the registered pharmacy premises.
ACTION
Contractors are advised to: Note the amendments
CPNI colleagues will keep you informed of any further amendments to medicines legislation which impact on the community pharmacy sector.
Yours sincerely
Mike
SENT ON BEHALF OF PROF MIKE MAWHINNEY | Head of Regulatory Affairs
Provision of the COVID Vaccine for Pharmacy Staff
Dear Colleague
Please see letterfrom Cathy Harrison, Chief Pharmaceutical Officer, DoH (NI) that provides confirmation and further information on the provision of the COVID Vaccine that will be made available to pharmacy staff members.
The letter also touches on the on-going development of plans for the inclusion of Community Pharmacy in the COVID Vaccination programme to the wider population in Northern Ireland.
Further information on both of these aspects will follow in due course this but I hope this initial letter provides reassurance to you and your pharmacy teams.
I trust this is helpful.
Yours sincerely
SENT ON BEHALF OF GERARD GREENE | Chief Executive
Provision of the COVID Vaccine for Pharmacy Staff
Dear
Colleague
Please
see letterfrom Cathy Harrison, Chief
Pharmaceutical Officer, DoH (NI) that provides confirmation and further
information on the provision of the COVID Vaccine that will be made
available to pharmacy staff members.
The letter also touches on the on-going development of plans for the
inclusion of Community Pharmacy in the COVID Vaccination programme to the
wider population in Northern Ireland.
Further information on both of these aspects will follow in due course
this but I hope this initial letter provides reassurance to you and your
pharmacy teams.
I trust this is helpful.
Yours sincerely
SENT ON BEHALF OF GERARD GREENE | Chief Executive
Seasonal Influenza Vaccination Programme 2020/21 Extension to 50-64 Year Olds
Dear Colleague
Please find letter here from Dr Michael McBride, Chief Medical Officer Prof Charlotte McArdle, Chief Nursing Officer and Mrs Cathy Harrison, Chief Pharmaceutical Officer.
SUMMARY
The Department of Health has extended the Seasonal influenza vaccination programme for 2020/2021 to include patients who will be aged 50-64 years old by 31st March 2021.
CPFV service is to be extended to include those aged from 50 to 64 years old, who are registered with a GP practice in NI, as well as the previous target group of Health and Social Care Workers.
The 50 to 64 year old cohort are able to receive the Cell-grown Quadrivalent Inactivated Vaccine (QIVc) or Egg- grown Quadrivalent Inactivated Vaccine (QIVe) through contracted community pharmacies or GP practices, free of charge.
CONTRACTOR ACTION
. The anticipated start date for the extended program is Monday 11th January 2021. . An updated contract will be distributed by HSCB, with the additional patient cohort, and will need to be signed and retained within the pharmacy for record purposes. . The service specification, PGD, privacy notice and all supporting documents are currently being amended to reflect the additional cohort of patients and will be added to www.pha.site/CPFV by the end of this week. . Updated Standard Operating Procedures will need to be amended and signed. . The CPFV e-record form is currently being updated to allow pharmacists to select the appropriate patient cohort. . Additional vaccine stock is available through Movianto and can be ordered in the normal way. . A communication plan is being developed between HSCB, PHA and CPNI and will be available shortly. . Posters to advertise the service will be distributed to contractors from HSCB in due course.
HSCB correspondence will be issued shortly on operational issues, but if you have any queries in the interim, please contact either: Chris Blayney chris.blayney@hscni.netor Greg Millergreg.miller@hscni.netor the CPNI office.
Yours sincerely
Vanessa
SENT ON BEHALF OF DR. VANESSA CHAMBERS | Head of Policy & Development
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.